EKSO Stock Summary and Trading Ideas (Ekso Bionics Holdings | NASDAQ:EKSO)

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

Ekso Bionics Holdings trades on the NASDAQ stock market under the symbol EKSO.

As of April 2, 2026, EKSO stock price declined to $9.40 with 209,055 million shares trading.

EKSO has a beta of 0.23, meaning it tends to be less sensitive to market movements. EKSO has a correlation of 0.00 to the broad based SPY ETF.

EKSO has a market cap of $33.49 million. This is considered a Sub-Micro Cap stock.

Last quarter Ekso Bionics Holdings reported $3 million in Revenue and -$1.56 earnings per share. This fell short of revenue expectation by $-1 million and missed earnings estimates by -$1.41.

In the last 3 years, EKSO traded as high as $703.91 and as low as $2.73.

The top ETF exchange traded funds that EKSO belongs to (by Net Assets): VXF, DFAC.

EKSO has underperformed the market in the last year with a price return of -89.9% while the SPY ETF gained +17.5%. However, in the short term, EKSO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +19.9% vs -3.7% return in SPY. But in the last 2 weeks, EKSO shares have been beat by the market, returning -9.6% compared to an SPY return of -0.1%.

EKSO support price is $10.00 and resistance is $11.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EKSO shares will trade within this expected range on the day.